KDA's Mission
The KDA is about to celebrate its 25th year. The KDA's mission has remained the same. To inform, support, educate, fund research and find a cure for Kennedy's Disease. Help us find a cure. Donate today
News & Events
2025 Grants and Fellowship Announcement
The Kennedy's Disease Association is pleased to announce its 2025 SBMA research grants and fellowship programs. Through these programs, we seek to further understand the pathological mechanisms of and possible treatments for Kennedy's disease. For details and proposal instructions, click here. The submission deadline for both programs is Monday, June 2, 2025. Awards will be announced in September after a review by the KDA's Scientific Review Board.
-
New research "Conscience Announces Recipients of Inaugural Program to Foster Collaborative Drug Discovery and Development - Project 1. Focus: Small Molecule PRMT6 Inhibitors for the Treatment of Spinal Bulbar Muscular Atrophy." To read the article, click here.
-
Kennedy's Disease is an adult-onset disease with symptoms usually appearing between the ages of 30 and 50. However, earlier and later onsets have been recorded. Life expectancy is noted to be at or almost normal. Generally males with this inherited gene develop symptoms, while females with this gene are carriers. For more information click here.
-
Kennedy's Disease support groups connect people living with and/or effected by Kennedy's Disease together for support. To find your group, click here.
-
KDA held its annual conference on November 2-4 in Orlando, FL. Approximately 250 patients, family members, clinicians, and researchers participated either in person or online. Four videos of the conference are available to watch. To watch these & other videos on KD, click here.
More News
Mr. Lewis Myers joins the Kennedy's Disease Association Board of Directors. Lewis brings a broad array of skills to the Kennedy’s Disease Association Board of Directors. To learn more about Lewis and other board members, click here.
